The prospect of artificial intelligence to personalize assisted reproductive technology

S Hanassab, A Abbara, AC Yeung, M Voliotis… - npj Digital …, 2024 - nature.com
Abstract Infertility affects 1-in-6 couples, with repeated intensive cycles of assisted
reproductive technology (ART) required by many to achieve a desired live birth. In ART …

Gonadotropins as pharmacological agents in assisted reproductive technology and polycystic ovary syndrome

R Singh, S Kaur, S Yadav, S Bhatia - Trends in Endocrinology & Metabolism, 2023 - cell.com
Polycystic ovary syndrome (PCOS) is a complex endocrinopathy associated with
subfertility/infertility and pregnancy complications. Most PCOS women opt for assisted …

Dose nomogram of individualization of the initial follicle-stimulating hormone dosage for patients with polycystic ovary syndrome undergoing IVF/ICSI with the GnRH …

M Si, X Qi, X Zhen, C Yang, T Tian, X Long, J Qiao - Advances in therapy, 2023 - Springer
Introduction For high responders with polycystic ovary syndrome (PCOS), there is no clear
recommendation for the initial follicle-stimulating hormone (FSH) dosage to ensure an …

Female infertility in the era of obesity: The clash of two pandemics or inevitable consequence?

S Medenica, ME Spoltore, P Ormazabal… - Clinical …, 2023 - Wiley Online Library
Obesity is an epidemic that has led to a rise in the incidence of many comorbidities: among
others, reduced fertility is often under‐evaluated in clinical practice. The mechanisms …

The essential role of body weight in adjusting Gn dosage to prevent high ovarian response for women with PCOS during IVF: A retrospective study

R Zeng, H Chen, X Zeng, L Qin - Frontiers in endocrinology, 2022 - frontiersin.org
Polycystic ovarian syndrome (PCOS) is the major cause of anovulatory infertility. Since
women with PCOS are often accompanied by increased body weight and hyper response to …

Clinical outcomes of potential high responders after individualized FSH dosing based on anti-Müllerian hormone and body weight

H Višnová, E Papaleo, FS Martin, K Koziol… - Reproductive …, 2021 - Elsevier
Research question How does the efficacy and safety of individualized follitropin delta dosing
compare with conventional dosing for ovarian stimulation in potential high responders …

Comparative clinical outcome following individualized follitropin delta dosing in Chinese women undergoing ovarian stimulation for in vitro fertilization …

R Yang, Y Zhang, X Liang, X Song, Z Wei, J Liu… - Reproductive Biology …, 2022 - Springer
Background To compare the efficacy and safety of follitropin delta in its individualized fixed-
dose regimen with follitropin alfa in a conventional adjustable dosing regimen in Chinese …

A Narrative Review Discussing the Efficiency of Personalized Dosing Algorithm of Follitropin Delta for Ovarian Stimulation and the Reproductive and Clinical …

B Doroftei, OD Ilie, N Anton, OA Marcu, IS Scripcariu… - Diagnostics, 2023 - mdpi.com
Background: Follitropin delta is the third recombinant human follicle-stimulating hormone (r-
hFSH) expressed in a host cell line of human fetal retinal origin that currently emphasizes …

Use of kisspeptin to trigger oocyte maturation during in vitro fertilisation (IVF) treatment

B Sharma, K Koysombat, AN Comninos… - Frontiers in …, 2022 - frontiersin.org
Infertility is a major global health issue and is associated with significant psychological
distress for afflicted couples. In vitro fertilisation (IVF) utilises supra-physiological doses of …

Traditional Chinese herbal medicine complex supplementation improves reproductive performance, serum biochemical parameters, and anti-oxidative capacity in …

M Ran, C Cha, Y Xu, H Zhang, Z Yang, Z Li… - Animal …, 2022 - Taylor & Francis
This study was conducted to investigate the effects of a traditional Chinese herbal medicine
complex (TCHMC) on the productive performance of periparturient dairy cows. Eighteen non …